<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02476318</url>
  </required_header>
  <id_info>
    <org_study_id>CLN-008</org_study_id>
    <nct_id>NCT02476318</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate the Safety and Performance of ArterX™ Vascular Sealant in Sealing Synthetic Arterial Grafts</brief_title>
  <official_title>A Study to Evaluate the Safety and Performance of ArterX™ Vascular Sealant in Sealing Synthetic Arterial Grafts</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tenaxis Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tenaxis Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, multi-center study to evaluate the safety and performance outcomes of the
      ArterX Vascular Sealant when used for prophylactic sealing of suture lines at the anastomosis
      between native vessel and synthetic vascular grafts.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <primary_completion_date type="Actual">August 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of anastomoses with immediate sealing of the suture line</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Immediate suture line sealing on clamp removal, as evidenced by a lack of clinically significant bleeding. A minimum of 50% of the anastomoses were expected to be sealed immediately.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Vascular Disease</condition>
  <arm_group>
    <arm_group_label>ArterX Vascular Sealant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ArterX Vascular Sealant</intervention_name>
    <arm_group_label>ArterX Vascular Sealant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The subject must be ≥ 18 years old

          2. The subject must be scheduled for surgical placement of a synthetic graft for large
             vessel repair/ arterial reconstruction/ hemodialysis access.

          3. The subject has no child bearing potential or has a negative serum or urine pregnancy
             test within 7 days of the index procedure.

          4. The subject is willing and able to be contacted for minimum of 6 weeks follow up.

          5. The subject or guardian must provide written informed consent using a form that is
             reviewed and approved by the Ethics Committee.

        Exclusion Criteria:

          1. The subject has a known hypersensitivity or contraindication to heparin, bovine or
             seafood products.

          2. The subject has a history of bleeding diathesis or coagulopathy, or will refuse blood
             transfusion.

          3. The subject is currently enrolled in this, or another investigational device or drug
             trail that has not completed the required follow-up period.

          4. ArterX Vascular Sealant should not be used in patients who have exhibited an allergic
             reaction to materials of shellfish or bovine origin.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hans J Florek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Krankenhaus Dresden Friedrichstadt Dresden, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Krankenhaus Dresden Friedrichstadt</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universitat zu Koln</name>
      <address>
        <city>Koln</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chirugische Uni Klinikum</name>
      <address>
        <city>Ulm</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2015</study_first_submitted>
  <study_first_submitted_qc>June 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2015</study_first_posted>
  <last_update_submitted>June 16, 2015</last_update_submitted>
  <last_update_submitted_qc>June 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

